---
title: "Outlook Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4499e982-2d30-5619-b9e4-d3fdd1688629
json: https://whiteintel.dev/api/public/dossier/4499e982-2d30-5619-b9e4-d3fdd1688629
identifier: sec:0001649989
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# Outlook Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001649989`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/4499e982-2d30-5619-b9e4-d3fdd1688629  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4499e982-2d30-5619-b9e4-d3fdd1688629  

## Ownership & control

### Owners / controllers

- **Sukhtian Ghiath M.** (10% owner) — https://whiteintel.dev/entity/6e1573e2-8efc-50e1-a054-0d006d3cdd39
- **GMS Ventures & Investments** (10% owner) — https://whiteintel.dev/entity/1605849d-1623-5eba-9f87-296cc9897008
- **GMS Ventures & Investments** (10% owner) — https://whiteintel.dev/entity/1605849d-1623-5eba-9f87-296cc9897008
- **Sukhtian Ghiath M.** (10% owner) — https://whiteintel.dev/entity/6e1573e2-8efc-50e1-a054-0d006d3cdd39
- **GMS Ventures & Investments** (tenpercentowner) — https://whiteintel.dev/entity/1605849d-1623-5eba-9f87-296cc9897008
- **Sukhtian Ghiath M.** (tenpercentowner) — https://whiteintel.dev/entity/6e1573e2-8efc-50e1-a054-0d006d3cdd39
- **SYNTONE VENTURES LLC** (tenpercentowner) — https://whiteintel.dev/entity/d8f2d3a9-3479-52ce-b280-b67876e5d2b3
- **Sukhtian Faisal Ghiath** (tenpercentowner) — https://whiteintel.dev/entity/779a2ce2-4f7f-5576-a688-4f9b25818276
- **BIOLEXIS PTE LTD.** (tenpercentowner) — https://whiteintel.dev/entity/bce5d2fd-abf1-5f88-95ef-cd009db5dde8
- **PILLAI ARUN KUMAR** (tenpercentowner) — https://whiteintel.dev/entity/004e0d3a-e21c-5438-b6d2-0c45b294f005
- **MOHAN PANKAJ** (tenpercentowner) — https://whiteintel.dev/entity/7fed59ba-9f50-51ea-aedd-021e435fce21

### UBO chain (walk to the ultimate owner)

A **47-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Outlook Therapeutics, Inc.** — https://whiteintel.dev/entity/4499e982-2d30-5619-b9e4-d3fdd1688629 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Outlook Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/4499e982-2d30-5619-b9e4-d3fdd1688629 · Structured JSON: https://whiteintel.dev/api/public/dossier/4499e982-2d30-5619-b9e4-d3fdd1688629._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._